FR2186230A1 - - Google Patents

Info

Publication number
FR2186230A1
FR2186230A1 FR7229465A FR7229465A FR2186230A1 FR 2186230 A1 FR2186230 A1 FR 2186230A1 FR 7229465 A FR7229465 A FR 7229465A FR 7229465 A FR7229465 A FR 7229465A FR 2186230 A1 FR2186230 A1 FR 2186230A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7229465A
Other languages
French (fr)
Other versions
FR2186230B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sutures Inc
Original Assignee
Sutures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutures Inc filed Critical Sutures Inc
Publication of FR2186230A1 publication Critical patent/FR2186230A1/fr
Application granted granted Critical
Publication of FR2186230B1 publication Critical patent/FR2186230B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
FR7229465A 1972-04-25 1972-08-17 Expired FR2186230B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24746672A 1972-04-25 1972-04-25

Publications (2)

Publication Number Publication Date
FR2186230A1 true FR2186230A1 (en) 1974-01-11
FR2186230B1 FR2186230B1 (en) 1976-07-02

Family

ID=22935052

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7229465A Expired FR2186230B1 (en) 1972-04-25 1972-08-17

Country Status (7)

Country Link
JP (1) JPS4920317A (en)
CA (1) CA950831A (en)
CH (1) CH553815A (en)
DE (1) DE2301633A1 (en)
FR (1) FR2186230B1 (en)
GB (1) GB1400464A (en)
ZA (1) ZA723917B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115001A2 (en) * 1982-12-28 1984-08-08 Bayer Ag Stable aminoglycoside-penicillin injection formulation
WO1998002145A2 (en) * 1996-07-16 1998-01-22 Gist-Brocades B.V. β-LACTAM GRANULES FREE OF ORGANIC SOLVENTS
US8106040B2 (en) 2006-09-26 2012-01-31 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN771596A0 (en) * 1996-01-25 1996-02-15 Mclean, Allan Joseph Methods of and compositions for potentiating the action of agents active on cell-wall sites of susceptible bacteria
IS6389A (en) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Experiences of antibiotic coating of carcasses containing microspheres, and also of such coated carcasses and their use
IS6390A (en) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Experiences of antibiotic coating of carcasses containing microspheres, thus coated carcasses and also of their use
DE10262176B4 (en) 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Process for the preparation of antibiotically coated porous bodies and use
WO2015112977A1 (en) 2014-01-27 2015-07-30 Susanne Gardner Antimicrobial formulations and applications thereof
WO2017019943A1 (en) * 2015-07-29 2017-02-02 Susanne Gardner Antimicrobial formulations and applications thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115001A2 (en) * 1982-12-28 1984-08-08 Bayer Ag Stable aminoglycoside-penicillin injection formulation
EP0115001A3 (en) * 1982-12-28 1986-05-14 Bayer Ag Stable aminoglycoside-penicillin injection formulation
WO1998002145A2 (en) * 1996-07-16 1998-01-22 Gist-Brocades B.V. β-LACTAM GRANULES FREE OF ORGANIC SOLVENTS
WO1998002145A3 (en) * 1996-07-16 1998-04-09 Gist Brocades Bv β-LACTAM GRANULES FREE OF ORGANIC SOLVENTS
US6242006B1 (en) 1996-07-16 2001-06-05 Gist-Brocades B.V. β-lactam granules free of organic solvents
US8106040B2 (en) 2006-09-26 2012-01-31 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
US8461143B2 (en) 2006-09-26 2013-06-11 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use

Also Published As

Publication number Publication date
CH553815A (en) 1974-09-13
DE2301633A1 (en) 1973-11-08
FR2186230B1 (en) 1976-07-02
CA950831A (en) 1974-07-09
ZA723917B (en) 1973-07-25
JPS4920317A (en) 1974-02-22
GB1400464A (en) 1975-07-16

Similar Documents

Publication Publication Date Title
FR2186230B1 (en)
JPS4945824A (en)
JPS4926145A (en)
JPS48102079A (en)
JPS4987569U (en)
JPS4962288U (en)
JPS4965262U (en)
JPS4926952A (en)
JPS4880841A (en)
JPS4954634U (en)
CS154087B1 (en)
JPS494016U (en)
JPS48106241U (en)
JPS4970986U (en)
CS155580B1 (en)
CS154994B1 (en)
CS154135B1 (en)
CH559286A5 (en)
CH564568A5 (en)
CH559322A5 (en)
CH559905A5 (en)
CH559313A5 (en)
CH577464A5 (en)
CH545744A (en)
NL7308676A (en)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse